WALTHAM, Mass. and VENLO, The Netherlands – July 16, 2020 – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA), a leading global provider of Sample to Insight molecular diagnostics and sample preparation technologies, today announced that they have entered into an amendment... Read more
LANSING, Mich., July 15, 2020 — NEOGEN Corporation (NASDAQ: NEOG) announced today that it has launched an advanced test system that automatically detects microorganisms in a fraction of the time of traditional testing methods. NEOGEN’s new Soleris® Next Generation (NG) can rapidly detect a wide variety of microorganisms that can threaten the safety and quality of food... Read more
Two-dimensional (2D) materials such as transition metal dichalcogenides (TMDs) are receiving increasing attention due to their unique optical and electronic properties. Their possible applications include the production of transistors, photo detectors, light emitting diodes (LEDs) and photovoltaic cells. In order to produce high-quality devices, synthesis processes must be evaluated efficiently. Thus, non-destructive imaging techniques are... Read more
End-to-end automatic cultivation of adherent stem cells and derivatives from a single instrument BERGISCH GLADBACH, 14 July 2020 – Miltenyi Biotec announced the immediate availability of its new CliniMACS Prodigy® Adherent Cell Culture System. A flexible architecture specifically developed for the GMP-compliant CliniMACS Prodigy Platform, it enables the automated, scalable, and closed manufacturing of various... Read more
Solid performance in context of COVID-19 market challenges Healthy longer-term commercial momentum with large, signature project wins Company to report second quarter earnings July 30, 2020 RYE BROOK, N.Y.–(BUSINESS WIRE)–Jul. 14, 2020– Global water technology company, Xylem Inc. (NYSE:XYL), today announced that for the quarter ended June 30, 2020, it expects revenue declines of approximately... Read more
Roche will obtain co-development and co-commercialisation rights for pralsetinib, an investigational, precision therapy in late-stage development for people with RET-altered non-small cell lung cancer, various types of thyroid cancer and other solid tumours. Blueprint Medicines and Roche will collaborate on the development of pralsetinib. Roche and Blueprint Medicines will co-commercialise pralsetinib in the US while... Read more
WASHINGTON, July 13, 2020 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2020 on Thursday, July 23, 2020 beginning at 8:00 a.m. ET and lasting approximately 1 hour. The call and an accompanying slide presentation will be webcast on the “Investors” section... Read more
Venlo, The Netherlands, July 13, 2020 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced additional information on preliminary results for the second quarter and first half of 2020, along with an outlook for continued strong growth trends in the third and fourth quarters of 2020. QIAGEN also provided initial perspectives that business trends are expected... Read more
WALTHAM, Mass.–(BUSINESS WIRE)–Jul. 13, 2020– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that it anticipates growth in both reported revenue and organic revenue1 of approximately 12% for the second quarter ended July 5, 2020. The strong revenue growth was driven by better-than-expected demand for PerkinElmer’s full-suite... Read more
Thermo Fisher Scientific and First Genetics JCS Partner to Develop Next-Generation Sequencing-Based Diagnostics in Russia CARLSBAD, Calif., July 13, 2020 /PRNewswire/ — Thermo Fisher Scientific and First Genetics JCS, a manufacturer of diagnostic equipment and IVD kits intended to advance molecular genetic technologies into clinical practice, today announced a strategic partnership focused on commercializing next-generation sequencing... Read more